Tag Archive for: consumer health

The company beat market estimates for fourth-quarter results today, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs pipeline, underscoring the benefits of its consumer health unit spin-off.

The British drugmaker said it sold around 300 million shares of Haleon, cutting its shareholding to 4.2%, as it expands its portfolio of specialty medicines.

Bayer is looking to shake things up with some major company changes after reporting “not acceptable” cash flow for the third quarter on Wednesday.

Johnson & Johnson said on Monday it was expecting to retain a stake of about 9.5% in its newly separated consumer health unit, Kenvue, after completing a share exchange offer.

Prescription drug sales would be flat and not up by about 1% as previously targeted, with the profit margin seen at about 28% this year, down from a previous goal of more than 29%.

The consumer health industry in Asia is transforming in front of our eyes; unsurprisingly for a population of 4.5 billion and a kaleidoscope of cultures. Health marketers must reassess their approach and brands must shift to a proactive digital-first mindset.

The offering will help J&J move a step closer in its plan to spin off the unit and focus on its larger medical devices and pharmaceuticals businesses.

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about 804 million pounds ($1 billion), the company said.

The company’s CFO said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained traction is because the selling window opens around the time that Haleon’s results are announced.

Haleon, carved out of British drugmaker last July in the biggest listing in Europe for more than a decade, is the world’s biggest standalone consumer health business selling non-prescription drugs, vitamins and oral care products.